0
Views
13
CrossRef citations to date
0
Altmetric
Review

Psychopharmacology of ADHD in pediatrics: current advances and issues

, &
Pages 171-181 | Published online: 05 Mar 2009

References

  • GreydanusDEPrattHDPatelDRAttention deficit hyperactivity disorder across the lifespanDis A Month200753265132
  • MayesRBagwellCErkulwaterJMedicating Children: ADHD and Pediatric Mental HealthCambridge, MassachusettsHarvard University Press2009
  • BarkleyRAAttention-deficit/hyperactivity disorderSci Am199866719725940
  • SoileauEJMedications with adolescents with attention-deficit/ hyperactivity disorderAdolesc Med200819254267
  • WolraichMLWibbelsmanCJBrownTEAttention deficit/ hyperactivity disorder among adolescentsPediatrics2005115173415930238
  • StauferWBGreydanusDEAttention-deficit/hyperactivity disorder: Psychopharmacology for college studentsPediatric Clin North Am2005527184
  • BiedermanJFaraoneSCAttention-deficit hyperactivity disorderLancet200536723724816023516
  • RobinASchubinerHColemanWLADHD/learning disordersAdolesc Med2008192209356
  • EpsteinJNLangbergJMLichtensteinPKCommunity-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physiciansPediatrics2008122192718595982
  • MayesRRafalovichASuffer the restless children: the evolution of ADHD and paediatric stimulant use: 1900–1980Hist Psychiatry200718(72 Pt 4):43545718590022
  • GreydanusDESloaneMARappleyMDPsychopharmacology of ADHD in adolescentsAdolesc Med20021359962412270803
  • GreydanusDEPrattHDSloaneMAAttention-deficit/ hyperactivity disorder in children and adolescents: Interventions for a complex costly clinical conundrumPediatr Clin North Am2003501049109214558681
  • HammernessPSurmanCMillerKUpdate on adult ADHDCurr Neurol Neurosci Rep20088849859
  • GreydanusDECallesJLPatelDRPediatric and Adolescent PsychopharmacologyCambridge, EnglandCambridge University Press2008
  • PierceDDixonCMWigalSBPharmacokinetics of methyl-phenidate transdermal system (MTS): results from a classroom studyJ Child Adolesc Psychopharmacol20081835536418759645
  • PatrickKCStraughnABPerkinsJSGonzálezMAEvolution of stimulants to treat ADHD: transdermal methylphenidateHum Psychopharmacol200924111719051222
  • GreydanusDEPharmacologic treatment of attention-deficit/ hyperactivity disorderIndian J Pediatrics2005722734
  • GreydanusDEPrattHDADHD in children and adolescentsGreydanusDEPatelDRPrattHDBehavioral pediatrics2nd edNew YorkiUniverse Publishers2006
  • SilvaRRMunixRPestreichLDexmethylphenidate extended release capsules in children with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20084719920818176337
  • SolantoMVArnstenAFTCastellanosFXThe Neuroscience of stimulant drug action in ADHDSolantoMVArnstenAFTCastellanosFXStimulant drugs and ADHDLondonOxford Univ Press2001355379
  • ZitoJMSaferDJdosReisSPsychotropic practice patterns for youth. A 10-year perspectiveArch Pediatr Adolesc Med2003157172512517190
  • CoxERHalloranDRHomanSMTrends in the prevalence of chronic medication use in children: 2002–2005Pediatrics2008122e1053e106118977954
  • VolkowNDFowlerJSWangGDingYGatleySJMechanism of action of methylphenidate: insights from PET imaging studiesJ Atten Disord20026Suppl 1S31S4312685517
  • Tourette’s Syndrome Study GroupTreatment of ADHD in children with tics: a randomized controlled trialNeurology200258452753611865128
  • PatelDRGreydanusDENeurological conditions and disability in adolescentsIntl J Disabil Hum Dev200873279282
  • JankovicJTourette’s syndromeN Engl J Med20013451184119211642235
  • PerrinJMFriedmanRAKnilansTKCardiovascular monitoring and stimulant drugs for attention deficit/hyperactivity disorderPediatrics200812245145318676566
  • VetterVLEliaJEricksonCCardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs. A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young, Congenital Cardiac Defects Committee and the Council on Cardiovascular NursingCirculation20081172407242318427125
  • FoneKCFNuttDJStimulants: use and abuse in the treatment of attention deficit hyperactivity disorderCurr Opin Pharmacol20055879315661631
  • WilensTEGignacMSwezeyACharacteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medicationsJ Am Acad Child Adolesc Psychiatry20064540841416601645
  • WilensTEFaraoneSVBiedermanJDoes stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literaturePediatrics200311117918512509574
  • GreydanusDEPatelDRThe adolescent and substance abuse: Current conceptsCurr Probl Pediatr Adolesc Health Care2005353789815723035
  • BramstedtKACaffeine use by children: quest for enhancementSubst Use Misuse2007421237125117674233
  • GehrickeJGLoughlinSEWhalenCKSmoking to self-mediate attentional and emotional dysfunctionNicotine Tob Res20079Suppl 4S523S53618067030
  • BradleyCThe behavior of children receiving benzedrineAm J Psychiatry1937577585
  • Lisdexafetamine dimesylate (Vyvanse) for ADHDMed Lett2007495859
  • LopezFAGinsbergLDArnoldVEffect of lisdexamfetamine dimethylate on parent-rated measures in children aged 6–12 years with attention-deficit hyperactivity disorder: a secondary analysisPost grad Med200812089102
  • http:www.fda.gov/medwatch/safety/2005/safety05.htm#Strattera
  • SpencerTBiedermanJWilensTEffectiveness and tolerability of atomoxetine in adults with attention-deficit hyperactivity disorderAm J Psychiatry19981556936959585725
  • MichelsonDAllenAJBusnerJOnce-daily atomoxetine treatment for children and adolescents with ADHD: A randomized, placebo-controlled studyAm J Psychiatry20021591896190112411225
  • Atomoxetine (Strattera) for ADHDMed Lett2003451112
  • AllenAJSpencerTJHeiligensteinJHSafety and efficacy of atomoxetine for AHDH in two double-blind, placebo-controlled trialsBiol Psychiatry200149Suppl 832S33S
  • BiedermannJMelmedRDPatelAGuanfacine extended release for Pediatric Attention deficit/hyperactivity disorderPediatrics2008121e73e8418166547
  • BiedermanJMelmedRDPatelAA randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with ADHDPediatrics2008121e73e8418166547
  • VarleyCSudden death of a child treated with imipramineJ Child Adolesc Psychopharmacol20001032132511191693
  • VarleyCKSudden death related to selected tricyclic antidepressants in children: Epidemiology, mechanisms and clinical implicationsPaediatr Drugs2001361362711577926
  • PliszkaSRGreenhillLLCrismonMLThe Texas Children’s Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part IJ Am Acad Child Adolesc Psychiatry20013990891910892234
  • DavissWBBuproprion for adolescents with attention-deficit/ hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20014030731411288772
  • Wilkes S BupropionDrugs Today20064210671681
  • FindlingRLGreenhillLLMcNamaraNKVenlafaxine in the treatment of children and adolescents with attention deficit hyperactivity disorderJ Child Adolesc Psychopharmacol20071743344517822339
  • TurnerDCClarkLDowsonJModafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorderBiol Psychiatry2004551031104015121488
  • LópezFAADHD: New pharmacologic treatments on the horizonJ Dev Behav Pediatr20062741041617041279
  • BiedermanJPliszkaSRModafanil improves symptoms of attention-deficit hyperactivity disorder across subtypes in children and adolescentsJ Pediatr200815239439918280848
  • BallonJSFeifelDA systemic review of modafanil: Potential clinical uses and mechanism of actionJ Clin Psychiatr200667554566
  • KumarRApproved and investigational uses of modafanil: An evidence-based reviewDrugs2008681803183918729534
  • SteinMAMcGoughJJThe pharmacogenomic era: promise for personalizing ADHD therapyChild Adolesc Psychiatry Clin N Amer200817475490
  • SwansonJMHechtmanLUsing long-acting stimulants: does it change ADHD treatment outcome?Can Child Adolesc Psychiatr Rev200514Suppl 12319030517
  • GreydanusDEMetilfenidato: Ventajas de metifenidato de liberacion immediata sobre las formulaciones de metifenidato de liberacion prolongadaEuromedice200723
  • DanyszWCX-516 Cortex PharmaceuticalsCurr Opin Invest Drugs2002310811088
  • WeislerRAEmerging drugs for ADHDExpert Opin Emerg Drugs20071242343417874970
  • LevinEDNicotinic receptor subtypes and cognitive functionNeurol Biol200253633646
  • AdlerLAChuaHCManagement of ADHD in adultsJ Clin Psychiatr200263Suppl 122935
  • KonofalEArnuufILecendreauxMMourenMCRopinirole in a child with attention-deficit hyperactivity disorder and restless legs syndromePediatr Neurol20053035035115866437
  • FindingRLEvolution of the treatment for attention-deficit hyperactivity disorder in children: a reviewClin Ther20083094295118555941
  • KarroumEKonofalEArnuufIRestless legs syndromeRev Neurol200816470172118656214
  • FindlingRLShortEJLeskovecTAripiprazole in children with ADHDJ Child Adolesc Psychopharmacol20081834735418759644
  • FindlingRLAtypical antipsychotic treatment of disruptive behavior disorders in children and adolescentsJ Clin Psychiatry200869Suppl 491418533763
  • TorenPRatnerSWeizmanAReboxetine maintenance treatment in children with ADHD: A long term follow-up studyJ Child Adolesc Psychopharmacol20071780381218315452
  • A new long-acting methylphenidate (Concerta)Med Lett2000428081
  • Another long-acting methylphenidate (Metadate CD)Med Lett2001438384
  • Dexmethylphenidate (Focalin) for ADHDMed Lett2002444546
  • PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20074689492117581453
  • HechtmanLGreenfieldBLong-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcomePaediatr Drugs2003578779414658920
  • LernerMWigalTLong-term safety of stimulant medications used to treat children with ADHDPediatr Ann200837374518240852
  • CallesJLADHD in children and adolescentsGreydanusDEPatelDRPrattHDBehavioral Pediatrics3rd edNew YorkNova Science Publishers2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.